Pharmaceutical Development, Syndax Pharmaceuticals, Waltham, Massachusetts, USA.
Biotechnology Discovery Research, Lilly Research Laboratories, Lilly Technology Center North, Indianapolis, Indiana, USA.
MAbs. 2021 Jan-Dec;13(1):1993768. doi: 10.1080/19420862.2021.1993768.
Immunoglobulin G-based monoclonal antibodies (mAbs) have become a dominant class of biotherapeutics in recent decades. Approved antibodies are mainly of the subclasses IgG1, IgG2, and IgG4, as well as their derivatives. Over the decades, the selection of IgG subclass has frequently been based on the needs of Fc gamma receptor engagement and effector functions for the desired mechanism of action, while the effect on drug product developability has been less thoroughly characterized. One of the major reasons is the lack of systematic understanding of the impact of IgG subclass on the molecular properties. Several efforts have been made recently to compare molecular property differences among these IgG subclasses, but the conclusions from these studies are sometimes obscured by the interference from variable regions. To further establish mechanistic understandings, we conducted a systematic study by grafting three independent variable regions onto human IgG1, an IgG1 variant, IgG2, and an IgG4 variant constant domains and evaluating the impact of subclass and variable regions on their molecular properties. Structural and computational analysis revealed specific molecular features that potentially account for the differential behavior of the IgG subclasses observed experimentally. Our data indicate that IgG subclass plays a significant role on molecular properties, either through direct effects or via the interplay with the variable region, the IgG1 mAbs tend to have higher solubility than either IgG2 or IgG4 mAbs in a common pH 6 buffer matrix, and solution behavior relies heavily on the charge status of the antibody at the desirable pH.
免疫球蛋白 G 基单克隆抗体 (mAb) 在近几十年来已成为生物治疗学的主要类别。已批准的抗体主要为 IgG1、IgG2 和 IgG4 亚类及其衍生物。几十年来,IgG 亚类的选择经常基于 Fcγ受体结合和效应功能的需要,以达到所需的作用机制,而对药物产品开发的影响则没有得到充分的描述。主要原因之一是缺乏对 IgG 亚类对分子特性影响的系统认识。最近,人们做出了一些努力来比较这些 IgG 亚类之间的分子特性差异,但这些研究的结论有时会因可变区的干扰而变得模糊不清。为了进一步建立机制理解,我们通过将三个独立的可变区嫁接到人 IgG1、IgG1 变体、IgG2 和 IgG4 变体的恒定区上,并评估亚类和可变区对它们的分子特性的影响,进行了一项系统的研究。结构和计算分析揭示了特定的分子特征,这些特征可能解释了实验中观察到的 IgG 亚类的差异行为。我们的数据表明,IgG 亚类对分子特性有显著影响,无论是通过直接影响还是与可变区的相互作用,在常见的 pH6 缓冲基质中,IgG1 mAb 比 IgG2 或 IgG4 mAb 具有更高的溶解度,并且溶液行为在很大程度上依赖于抗体在理想 pH 值下的电荷状态。